ArticleTherapeutic advances in medical oncology2023

Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study.

Xiongwen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.